Global Blood Plasma Fractionation Market 2025 by Company, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Blood Plasma Fractionation market size was valued at US$ 33650 million in 2024 and is forecast to a readjusted size of USD 50830 million by 2031 with a CAGR of 7.3% during review period.
Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Blood Plasma Fractionation. In this report, we mainly study the Blood Plasma Fractionation products, such as: Immune Globulin, Coagulation Factor, Albumin, etc.
Market Drivers:
Increasing Demand for Plasma-Derived Therapies: The rising prevalence of chronic diseases, such as immune deficiencies, hemophilia, and autoimmune disorders, has led to increased demand for plasma-derived products like immunoglobulins, clotting factors, and albumin, driving the blood plasma fractionation market.
Aging Population: The global aging population is more prone to chronic diseases and conditions requiring plasma-derived therapies, contributing to the growth of the plasma fractionation market.
Growing Use of Immunoglobulins: Immunoglobulins are increasingly used in the treatment of a wide range of diseases, including primary and secondary immune deficiencies, boosting the need for blood plasma fractionation to produce these therapies.
Rising Healthcare Expenditure and Improved Healthcare Access: Expanding healthcare infrastructure in developing countries, combined with rising healthcare expenditure, is driving demand for advanced medical treatments and plasma-derived products.
Market Challenges:
High Costs of Plasma-Derived Products: The complex and time-consuming process of plasma fractionation leads to high costs for plasma-derived products, making these treatments less accessible, particularly in low-income regions.
Limited Plasma Supply: The availability of plasma for fractionation is often limited by low donation rates, regulatory restrictions, and the lengthy process of screening and collecting plasma, leading to supply shortages.
Stringent Regulatory Framework: Plasma fractionation is subject to rigorous regulatory requirements to ensure safety and efficacy. Meeting these regulations can increase development costs and slow the introduction of new products to the market.
Complex Manufacturing Process: The plasma fractionation process is technically challenging and requires significant investment in infrastructure, equipment, and skilled labor, posing barriers for new entrants and smaller manufacturers.
The outbreak of COVID-19 pandemic has led to decrease in number of blood donations and plasma collections, which hampers the market growth as it leads to shortage in raw material supply.
The classification of Blood Plasma Fractionation includes Immune Globulin, Coagulation Factor, Albumin and Other. In 2023, Immune Globulin accounted for a share of 51% in the global Blood Plasma Fractionation market.
North America is the largest consumption place, with a revenue market share nearly 40 % in 2023. Following North America, Europe is the second largest consumption place with the revenue market share of 24 %; China is also an important sales region for the Blood Plasma Fractionation.
This report is a detailed and comprehensive analysis for global Blood Plasma Fractionation market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Blood Plasma Fractionation market size and forecasts, in consumption value ($ Million), 2020-2031
Global Blood Plasma Fractionation market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Blood Plasma Fractionation market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Blood Plasma Fractionation market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Blood Plasma Fractionation
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Blood Plasma Fractionation market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Blood Plasma Fractionation market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Blood Plasma Fractionation product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Blood Plasma Fractionation, with revenue, gross margin, and global market share of Blood Plasma Fractionation from 2020 to 2025.
Chapter 3, the Blood Plasma Fractionation competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Blood Plasma Fractionation market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Blood Plasma Fractionation.
Chapter 13, to describe Blood Plasma Fractionation research findings and conclusion.
Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Blood Plasma Fractionation. In this report, we mainly study the Blood Plasma Fractionation products, such as: Immune Globulin, Coagulation Factor, Albumin, etc.
Market Drivers:
Increasing Demand for Plasma-Derived Therapies: The rising prevalence of chronic diseases, such as immune deficiencies, hemophilia, and autoimmune disorders, has led to increased demand for plasma-derived products like immunoglobulins, clotting factors, and albumin, driving the blood plasma fractionation market.
Aging Population: The global aging population is more prone to chronic diseases and conditions requiring plasma-derived therapies, contributing to the growth of the plasma fractionation market.
Growing Use of Immunoglobulins: Immunoglobulins are increasingly used in the treatment of a wide range of diseases, including primary and secondary immune deficiencies, boosting the need for blood plasma fractionation to produce these therapies.
Rising Healthcare Expenditure and Improved Healthcare Access: Expanding healthcare infrastructure in developing countries, combined with rising healthcare expenditure, is driving demand for advanced medical treatments and plasma-derived products.
Market Challenges:
High Costs of Plasma-Derived Products: The complex and time-consuming process of plasma fractionation leads to high costs for plasma-derived products, making these treatments less accessible, particularly in low-income regions.
Limited Plasma Supply: The availability of plasma for fractionation is often limited by low donation rates, regulatory restrictions, and the lengthy process of screening and collecting plasma, leading to supply shortages.
Stringent Regulatory Framework: Plasma fractionation is subject to rigorous regulatory requirements to ensure safety and efficacy. Meeting these regulations can increase development costs and slow the introduction of new products to the market.
Complex Manufacturing Process: The plasma fractionation process is technically challenging and requires significant investment in infrastructure, equipment, and skilled labor, posing barriers for new entrants and smaller manufacturers.
The outbreak of COVID-19 pandemic has led to decrease in number of blood donations and plasma collections, which hampers the market growth as it leads to shortage in raw material supply.
The classification of Blood Plasma Fractionation includes Immune Globulin, Coagulation Factor, Albumin and Other. In 2023, Immune Globulin accounted for a share of 51% in the global Blood Plasma Fractionation market.
North America is the largest consumption place, with a revenue market share nearly 40 % in 2023. Following North America, Europe is the second largest consumption place with the revenue market share of 24 %; China is also an important sales region for the Blood Plasma Fractionation.
This report is a detailed and comprehensive analysis for global Blood Plasma Fractionation market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Blood Plasma Fractionation market size and forecasts, in consumption value ($ Million), 2020-2031
Global Blood Plasma Fractionation market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Blood Plasma Fractionation market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Blood Plasma Fractionation market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Blood Plasma Fractionation
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Blood Plasma Fractionation market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Blood Plasma Fractionation market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Immune Globulin
- Coagulation Factor
- Albumin
- Other
- Hospital
- Retail Pharmacy
- Other
- Takeda
- CSL
- Grifols
- Octapharma
- Kedrion
- LFB Group
- Biotest
- BPL
- RAAS
- CBPO
- Hualan Bio
- Tiantan Bio
- Shuanglin Bio
- Boya Bio
- Yuanda Shuyang
- Weiguang Bio
- Nanyue Bio
- KM Biologics
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Blood Plasma Fractionation product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Blood Plasma Fractionation, with revenue, gross margin, and global market share of Blood Plasma Fractionation from 2020 to 2025.
Chapter 3, the Blood Plasma Fractionation competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Blood Plasma Fractionation market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Blood Plasma Fractionation.
Chapter 13, to describe Blood Plasma Fractionation research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Blood Plasma Fractionation by Type
1.3.1 Overview: Global Blood Plasma Fractionation Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Blood Plasma Fractionation Consumption Value Market Share by Type in 2024
1.3.3 Immune Globulin
1.3.4 Coagulation Factor
1.3.5 Albumin
1.3.6 Other
1.4 Global Blood Plasma Fractionation Market by Application
1.4.1 Overview: Global Blood Plasma Fractionation Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospital
1.4.3 Retail Pharmacy
1.4.4 Other
1.5 Global Blood Plasma Fractionation Market Size & Forecast
1.6 Global Blood Plasma Fractionation Market Size and Forecast by Region
1.6.1 Global Blood Plasma Fractionation Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Blood Plasma Fractionation Market Size by Region, (2020-2031)
1.6.3 North America Blood Plasma Fractionation Market Size and Prospect (2020-2031)
1.6.4 Europe Blood Plasma Fractionation Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Blood Plasma Fractionation Market Size and Prospect (2020-2031)
1.6.6 South America Blood Plasma Fractionation Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Blood Plasma Fractionation Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Takeda
2.1.1 Takeda Details
2.1.2 Takeda Major Business
2.1.3 Takeda Blood Plasma Fractionation Product and Solutions
2.1.4 Takeda Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Takeda Recent Developments and Future Plans
2.2 CSL
2.2.1 CSL Details
2.2.2 CSL Major Business
2.2.3 CSL Blood Plasma Fractionation Product and Solutions
2.2.4 CSL Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 CSL Recent Developments and Future Plans
2.3 Grifols
2.3.1 Grifols Details
2.3.2 Grifols Major Business
2.3.3 Grifols Blood Plasma Fractionation Product and Solutions
2.3.4 Grifols Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Grifols Recent Developments and Future Plans
2.4 Octapharma
2.4.1 Octapharma Details
2.4.2 Octapharma Major Business
2.4.3 Octapharma Blood Plasma Fractionation Product and Solutions
2.4.4 Octapharma Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Octapharma Recent Developments and Future Plans
2.5 Kedrion
2.5.1 Kedrion Details
2.5.2 Kedrion Major Business
2.5.3 Kedrion Blood Plasma Fractionation Product and Solutions
2.5.4 Kedrion Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Kedrion Recent Developments and Future Plans
2.6 LFB Group
2.6.1 LFB Group Details
2.6.2 LFB Group Major Business
2.6.3 LFB Group Blood Plasma Fractionation Product and Solutions
2.6.4 LFB Group Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 LFB Group Recent Developments and Future Plans
2.7 Biotest
2.7.1 Biotest Details
2.7.2 Biotest Major Business
2.7.3 Biotest Blood Plasma Fractionation Product and Solutions
2.7.4 Biotest Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Biotest Recent Developments and Future Plans
2.8 BPL
2.8.1 BPL Details
2.8.2 BPL Major Business
2.8.3 BPL Blood Plasma Fractionation Product and Solutions
2.8.4 BPL Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 BPL Recent Developments and Future Plans
2.9 RAAS
2.9.1 RAAS Details
2.9.2 RAAS Major Business
2.9.3 RAAS Blood Plasma Fractionation Product and Solutions
2.9.4 RAAS Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 RAAS Recent Developments and Future Plans
2.10 CBPO
2.10.1 CBPO Details
2.10.2 CBPO Major Business
2.10.3 CBPO Blood Plasma Fractionation Product and Solutions
2.10.4 CBPO Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 CBPO Recent Developments and Future Plans
2.11 Hualan Bio
2.11.1 Hualan Bio Details
2.11.2 Hualan Bio Major Business
2.11.3 Hualan Bio Blood Plasma Fractionation Product and Solutions
2.11.4 Hualan Bio Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Hualan Bio Recent Developments and Future Plans
2.12 Tiantan Bio
2.12.1 Tiantan Bio Details
2.12.2 Tiantan Bio Major Business
2.12.3 Tiantan Bio Blood Plasma Fractionation Product and Solutions
2.12.4 Tiantan Bio Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Tiantan Bio Recent Developments and Future Plans
2.13 Shuanglin Bio
2.13.1 Shuanglin Bio Details
2.13.2 Shuanglin Bio Major Business
2.13.3 Shuanglin Bio Blood Plasma Fractionation Product and Solutions
2.13.4 Shuanglin Bio Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Shuanglin Bio Recent Developments and Future Plans
2.14 Boya Bio
2.14.1 Boya Bio Details
2.14.2 Boya Bio Major Business
2.14.3 Boya Bio Blood Plasma Fractionation Product and Solutions
2.14.4 Boya Bio Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Boya Bio Recent Developments and Future Plans
2.15 Yuanda Shuyang
2.15.1 Yuanda Shuyang Details
2.15.2 Yuanda Shuyang Major Business
2.15.3 Yuanda Shuyang Blood Plasma Fractionation Product and Solutions
2.15.4 Yuanda Shuyang Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Yuanda Shuyang Recent Developments and Future Plans
2.16 Weiguang Bio
2.16.1 Weiguang Bio Details
2.16.2 Weiguang Bio Major Business
2.16.3 Weiguang Bio Blood Plasma Fractionation Product and Solutions
2.16.4 Weiguang Bio Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Weiguang Bio Recent Developments and Future Plans
2.17 Nanyue Bio
2.17.1 Nanyue Bio Details
2.17.2 Nanyue Bio Major Business
2.17.3 Nanyue Bio Blood Plasma Fractionation Product and Solutions
2.17.4 Nanyue Bio Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 Nanyue Bio Recent Developments and Future Plans
2.18 KM Biologics
2.18.1 KM Biologics Details
2.18.2 KM Biologics Major Business
2.18.3 KM Biologics Blood Plasma Fractionation Product and Solutions
2.18.4 KM Biologics Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
2.18.5 KM Biologics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Blood Plasma Fractionation Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Blood Plasma Fractionation by Company Revenue
3.2.2 Top 3 Blood Plasma Fractionation Players Market Share in 2024
3.2.3 Top 6 Blood Plasma Fractionation Players Market Share in 2024
3.3 Blood Plasma Fractionation Market: Overall Company Footprint Analysis
3.3.1 Blood Plasma Fractionation Market: Region Footprint
3.3.2 Blood Plasma Fractionation Market: Company Product Type Footprint
3.3.3 Blood Plasma Fractionation Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Blood Plasma Fractionation Consumption Value and Market Share by Type (2020-2025)
4.2 Global Blood Plasma Fractionation Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Blood Plasma Fractionation Consumption Value Market Share by Application (2020-2025)
5.2 Global Blood Plasma Fractionation Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Blood Plasma Fractionation Consumption Value by Type (2020-2031)
6.2 North America Blood Plasma Fractionation Market Size by Application (2020-2031)
6.3 North America Blood Plasma Fractionation Market Size by Country
6.3.1 North America Blood Plasma Fractionation Consumption Value by Country (2020-2031)
6.3.2 United States Blood Plasma Fractionation Market Size and Forecast (2020-2031)
6.3.3 Canada Blood Plasma Fractionation Market Size and Forecast (2020-2031)
6.3.4 Mexico Blood Plasma Fractionation Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Blood Plasma Fractionation Consumption Value by Type (2020-2031)
7.2 Europe Blood Plasma Fractionation Consumption Value by Application (2020-2031)
7.3 Europe Blood Plasma Fractionation Market Size by Country
7.3.1 Europe Blood Plasma Fractionation Consumption Value by Country (2020-2031)
7.3.2 Germany Blood Plasma Fractionation Market Size and Forecast (2020-2031)
7.3.3 France Blood Plasma Fractionation Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Blood Plasma Fractionation Market Size and Forecast (2020-2031)
7.3.5 Russia Blood Plasma Fractionation Market Size and Forecast (2020-2031)
7.3.6 Italy Blood Plasma Fractionation Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Blood Plasma Fractionation Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Blood Plasma Fractionation Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Blood Plasma Fractionation Market Size by Region
8.3.1 Asia-Pacific Blood Plasma Fractionation Consumption Value by Region (2020-2031)
8.3.2 China Blood Plasma Fractionation Market Size and Forecast (2020-2031)
8.3.3 Japan Blood Plasma Fractionation Market Size and Forecast (2020-2031)
8.3.4 South Korea Blood Plasma Fractionation Market Size and Forecast (2020-2031)
8.3.5 India Blood Plasma Fractionation Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Blood Plasma Fractionation Market Size and Forecast (2020-2031)
8.3.7 Australia Blood Plasma Fractionation Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Blood Plasma Fractionation Consumption Value by Type (2020-2031)
9.2 South America Blood Plasma Fractionation Consumption Value by Application (2020-2031)
9.3 South America Blood Plasma Fractionation Market Size by Country
9.3.1 South America Blood Plasma Fractionation Consumption Value by Country (2020-2031)
9.3.2 Brazil Blood Plasma Fractionation Market Size and Forecast (2020-2031)
9.3.3 Argentina Blood Plasma Fractionation Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Blood Plasma Fractionation Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Blood Plasma Fractionation Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Blood Plasma Fractionation Market Size by Country
10.3.1 Middle East & Africa Blood Plasma Fractionation Consumption Value by Country (2020-2031)
10.3.2 Turkey Blood Plasma Fractionation Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Blood Plasma Fractionation Market Size and Forecast (2020-2031)
10.3.4 UAE Blood Plasma Fractionation Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Blood Plasma Fractionation Market Drivers
11.2 Blood Plasma Fractionation Market Restraints
11.3 Blood Plasma Fractionation Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Blood Plasma Fractionation Industry Chain
12.2 Blood Plasma Fractionation Upstream Analysis
12.3 Blood Plasma Fractionation Midstream Analysis
12.4 Blood Plasma Fractionation Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OFTABLES
Table 1. Global Blood PlasmaFractionation Consumption Value byType, (USD Million), 2020 & 2024 & 2031
Table 2. Global Blood PlasmaFractionation Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Blood PlasmaFractionation Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Blood PlasmaFractionation Consumption Value by Region (2026-2031) & (USD Million)
Table 5.Takeda Company Information, Head Office, and Major Competitors
Table 6.Takeda Major Business
Table 7.Takeda Blood PlasmaFractionation Product and Solutions
Table 8.Takeda Blood PlasmaFractionation Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9.Takeda Recent Developments andFuture Plans
Table 10. CSL Company Information, Head Office, and Major Competitors
Table 11. CSL Major Business
Table 12. CSL Blood PlasmaFractionation Product and Solutions
Table 13. CSL Blood PlasmaFractionation Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. CSL Recent Developments andFuture Plans
Table 15. Grifols Company Information, Head Office, and Major Competitors
Table 16. Grifols Major Business
Table 17. Grifols Blood PlasmaFractionation Product and Solutions
Table 18. Grifols Blood PlasmaFractionation Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Octapharma Company Information, Head Office, and Major Competitors
Table 20. Octapharma Major Business
Table 21. Octapharma Blood PlasmaFractionation Product and Solutions
Table 22. Octapharma Blood PlasmaFractionation Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Octapharma Recent Developments andFuture Plans
Table 24. Kedrion Company Information, Head Office, and Major Competitors
Table 25. Kedrion Major Business
Table 26. Kedrion Blood PlasmaFractionation Product and Solutions
Table 27. Kedrion Blood PlasmaFractionation Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Kedrion Recent Developments andFuture Plans
Table 29. LFB Group Company Information, Head Office, and Major Competitors
Table 30. LFB Group Major Business
Table 31. LFB Group Blood PlasmaFractionation Product and Solutions
Table 32. LFB Group Blood PlasmaFractionation Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. LFB Group Recent Developments andFuture Plans
Table 34. Biotest Company Information, Head Office, and Major Competitors
Table 35. Biotest Major Business
Table 36. Biotest Blood PlasmaFractionation Product and Solutions
Table 37. Biotest Blood PlasmaFractionation Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Biotest Recent Developments andFuture Plans
Table 39. BPL Company Information, Head Office, and Major Competitors
Table 40. BPL Major Business
Table 41. BPL Blood PlasmaFractionation Product and Solutions
Table 42. BPL Blood PlasmaFractionation Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. BPL Recent Developments andFuture Plans
Table 44. RAAS Company Information, Head Office, and Major Competitors
Table 45. RAAS Major Business
Table 46. RAAS Blood PlasmaFractionation Product and Solutions
Table 47. RAAS Blood PlasmaFractionation Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. RAAS Recent Developments andFuture Plans
Table 49. CBPO Company Information, Head Office, and Major Competitors
Table 50. CBPO Major Business
Table 51. CBPO Blood PlasmaFractionation Product and Solutions
Table 52. CBPO Blood PlasmaFractionation Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. CBPO Recent Developments andFuture Plans
Table 54. Hualan Bio Company Information, Head Office, and Major Competitors
Table 55. Hualan Bio Major Business
Table 56. Hualan Bio Blood PlasmaFractionation Product and Solutions
Table 57. Hualan Bio Blood PlasmaFractionation Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. Hualan Bio Recent Developments andFuture Plans
Table 59.Tiantan Bio Company Information, Head Office, and Major Competitors
Table 60.Tiantan Bio Major Business
Table 61.Tiantan Bio Blood PlasmaFractionation Product and Solutions
Table 62.Tiantan Bio Blood PlasmaFractionation Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63.Tiantan Bio Recent Developments andFuture Plans
Table 64. Shuanglin Bio Company Information, Head Office, and Major Competitors
Table 65. Shuanglin Bio Major Business
Table 66. Shuanglin Bio Blood PlasmaFractionation Product and Solutions
Table 67. Shuanglin Bio Blood PlasmaFractionation Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 68. Shuanglin Bio Recent Developments andFuture Plans
Table 69. Boya Bio Company Information, Head Office, and Major Competitors
Table 70. Boya Bio Major Business
Table 71. Boya Bio Blood PlasmaFractionation Product and Solutions
Table 72. Boya Bio Blood PlasmaFractionation Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 73. Boya Bio Recent Developments andFuture Plans
Table 74. Yuanda Shuyang Company Information, Head Office, and Major Competitors
Table 75. Yuanda Shuyang Major Business
Table 76. Yuanda Shuyang Blood PlasmaFractionation Product and Solutions
Table 77. Yuanda Shuyang Blood PlasmaFractionation Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 78. Yuanda Shuyang Recent Developments andFuture Plans
Table 79. Weiguang Bio Company Information, Head Office, and Major Competitors
Table 80. Weiguang Bio Major Business
Table 81. Weiguang Bio Blood PlasmaFractionation Product and Solutions
Table 82. Weiguang Bio Blood PlasmaFractionation Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 83. Weiguang Bio Recent Developments andFuture Plans
Table 84. Nanyue Bio Company Information, Head Office, and Major Competitors
Table 85. Nanyue Bio Major Business
Table 86. Nanyue Bio Blood PlasmaFractionation Product and Solutions
Table 87. Nanyue Bio Blood PlasmaFractionation Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 88. Nanyue Bio Recent Developments andFuture Plans
Table 89. KM Biologics Company Information, Head Office, and Major Competitors
Table 90. KM Biologics Major Business
Table 91. KM Biologics Blood PlasmaFractionation Product and Solutions
Table 92. KM Biologics Blood PlasmaFractionation Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 93. KM Biologics Recent Developments andFuture Plans
Table 94. Global Blood PlasmaFractionation Revenue (USD Million) by Players (2020-2025)
Table 95. Global Blood PlasmaFractionation Revenue Share by Players (2020-2025)
Table 96. Breakdown of Blood PlasmaFractionation by CompanyType (Tier 1,Tier 2, andTier 3)
Table 97. Market Position of Players in Blood PlasmaFractionation, (Tier 1,Tier 2, andTier 3), Based on Revenue in 2024
Table 98. Head Office of Key Blood PlasmaFractionation Players
Table 99. Blood PlasmaFractionation Market: Company ProductTypeFootprint
Table 100. Blood PlasmaFractionation Market: Company Product ApplicationFootprint
Table 101. Blood PlasmaFractionation New Market Entrants and Barriers to Market Entry
Table 102. Blood PlasmaFractionation Mergers, Acquisition, Agreements, and Collaborations
Table 103. Global Blood PlasmaFractionation Consumption Value (USD Million) byType (2020-2025)
Table 104. Global Blood PlasmaFractionation Consumption Value Share byType (2020-2025)
Table 105. Global Blood PlasmaFractionation Consumption ValueForecast byType (2026-2031)
Table 106. Global Blood PlasmaFractionation Consumption Value by Application (2020-2025)
Table 107. Global Blood PlasmaFractionation Consumption ValueForecast by Application (2026-2031)
Table 108. North America Blood PlasmaFractionation Consumption Value byType (2020-2025) & (USD Million)
Table 109. North America Blood PlasmaFractionation Consumption Value byType (2026-2031) & (USD Million)
Table 110. North America Blood PlasmaFractionation Consumption Value by Application (2020-2025) & (USD Million)
Table 111. North America Blood PlasmaFractionation Consumption Value by Application (2026-2031) & (USD Million)
Table 112. North America Blood PlasmaFractionation Consumption Value by Country (2020-2025) & (USD Million)
Table 113. North America Blood PlasmaFractionation Consumption Value by Country (2026-2031) & (USD Million)
Table 114. Europe Blood PlasmaFractionation Consumption Value byType (2020-2025) & (USD Million)
Table 115. Europe Blood PlasmaFractionation Consumption Value byType (2026-2031) & (USD Million)
Table 116. Europe Blood PlasmaFractionation Consumption Value by Application (2020-2025) & (USD Million)
Table 117. Europe Blood PlasmaFractionation Consumption Value by Application (2026-2031) & (USD Million)
Table 118. Europe Blood PlasmaFractionation Consumption Value by Country (2020-2025) & (USD Million)
Table 119. Europe Blood PlasmaFractionation Consumption Value by Country (2026-2031) & (USD Million)
Table 120. Asia-Pacific Blood PlasmaFractionation Consumption Value byType (2020-2025) & (USD Million)
Table 121. Asia-Pacific Blood PlasmaFractionation Consumption Value byType (2026-2031) & (USD Million)
Table 122. Asia-Pacific Blood PlasmaFractionation Consumption Value by Application (2020-2025) & (USD Million)
Table 123. Asia-Pacific Blood PlasmaFractionation Consumption Value by Application (2026-2031) & (USD Million)
Table 124. Asia-Pacific Blood PlasmaFractionation Consumption Value by Region (2020-2025) & (USD Million)
Table 125. Asia-Pacific Blood PlasmaFractionation Consumption Value by Region (2026-2031) & (USD Million)
Table 126. South America Blood PlasmaFractionation Consumption Value byType (2020-2025) & (USD Million)
Table 127. South America Blood PlasmaFractionation Consumption Value byType (2026-2031) & (USD Million)
Table 128. South America Blood PlasmaFractionation Consumption Value by Application (2020-2025) & (USD Million)
Table 129. South America Blood PlasmaFractionation Consumption Value by Application (2026-2031) & (USD Million)
Table 130. South America Blood PlasmaFractionation Consumption Value by Country (2020-2025) & (USD Million)
Table 131. South America Blood PlasmaFractionation Consumption Value by Country (2026-2031) & (USD Million)
Table 132. Middle East & Africa Blood PlasmaFractionation Consumption Value byType (2020-2025) & (USD Million)
Table 133. Middle East & Africa Blood PlasmaFractionation Consumption Value byType (2026-2031) & (USD Million)
Table 134. Middle East & Africa Blood PlasmaFractionation Consumption Value by Application (2020-2025) & (USD Million)
Table 135. Middle East & Africa Blood PlasmaFractionation Consumption Value by Application (2026-2031) & (USD Million)
Table 136. Middle East & Africa Blood PlasmaFractionation Consumption Value by Country (2020-2025) & (USD Million)
Table 137. Middle East & Africa Blood PlasmaFractionation Consumption Value by Country (2026-2031) & (USD Million)
Table 138. Global Key Players of Blood PlasmaFractionation Upstream (Raw Materials)
Table 139. Global Blood PlasmaFractionationTypical Customers
LIST OFFIGURES
Figure 1. Blood PlasmaFractionation Picture
Figure 2. Global Blood PlasmaFractionation Consumption Value byType, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Blood PlasmaFractionation Consumption Value Market Share byType in 2024
Figure 4. Immune Globulin
Figure 5. CoagulationFactor
Figure 6. Albumin
Figure 7. Other
Figure 8. Global Blood PlasmaFractionation Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 9. Blood PlasmaFractionation Consumption Value Market Share by Application in 2024
Figure 10. Hospital Picture
Figure 11. Retail Pharmacy Picture
Figure 12. Other Picture
Figure 13. Global Blood PlasmaFractionation Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 14. Global Blood PlasmaFractionation Consumption Value andForecast (2020-2031) & (USD Million)
Figure 15. Global Market Blood PlasmaFractionation Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 16. Global Blood PlasmaFractionation Consumption Value Market Share by Region (2020-2031)
Figure 17. Global Blood PlasmaFractionation Consumption Value Market Share by Region in 2024
Figure 18. North America Blood PlasmaFractionation Consumption Value (2020-2031) & (USD Million)
Figure 19. Europe Blood PlasmaFractionation Consumption Value (2020-2031) & (USD Million)
Figure 20. Asia-Pacific Blood PlasmaFractionation Consumption Value (2020-2031) & (USD Million)
Figure 21. South America Blood PlasmaFractionation Consumption Value (2020-2031) & (USD Million)
Figure 22. Middle East & Africa Blood PlasmaFractionation Consumption Value (2020-2031) & (USD Million)
Figure 23. CompanyThree Recent Developments andFuture Plans
Figure 24. Global Blood PlasmaFractionation Revenue Share by Players in 2024
Figure 25. Blood PlasmaFractionation Market Share by CompanyType (Tier 1,Tier 2, andTier 3) in 2024
Figure 26. Market Share of Blood PlasmaFractionation by Player Revenue in 2024
Figure 27.Top 3 Blood PlasmaFractionation Players Market Share in 2024
Figure 28.Top 6 Blood PlasmaFractionation Players Market Share in 2024
Figure 29. Global Blood PlasmaFractionation Consumption Value Share byType (2020-2025)
Figure 30. Global Blood PlasmaFractionation Market ShareForecast byType (2026-2031)
Figure 31. Global Blood PlasmaFractionation Consumption Value Share by Application (2020-2025)
Figure 32. Global Blood PlasmaFractionation Market ShareForecast by Application (2026-2031)
Figure 33. North America Blood PlasmaFractionation Consumption Value Market Share byType (2020-2031)
Figure 34. North America Blood PlasmaFractionation Consumption Value Market Share by Application (2020-2031)
Figure 35. North America Blood PlasmaFractionation Consumption Value Market Share by Country (2020-2031)
Figure 36. United States Blood PlasmaFractionation Consumption Value (2020-2031) & (USD Million)
Figure 37. Canada Blood PlasmaFractionation Consumption Value (2020-2031) & (USD Million)
Figure 38. Mexico Blood PlasmaFractionation Consumption Value (2020-2031) & (USD Million)
Figure 39. Europe Blood PlasmaFractionation Consumption Value Market Share byType (2020-2031)
Figure 40. Europe Blood PlasmaFractionation Consumption Value Market Share by Application (2020-2031)
Figure 41. Europe Blood PlasmaFractionation Consumption Value Market Share by Country (2020-2031)
Figure 42. Germany Blood PlasmaFractionation Consumption Value (2020-2031) & (USD Million)
Figure 43.France Blood PlasmaFractionation Consumption Value (2020-2031) & (USD Million)
Figure 44. United Kingdom Blood PlasmaFractionation Consumption Value (2020-2031) & (USD Million)
Figure 45. Russia Blood PlasmaFractionation Consumption Value (2020-2031) & (USD Million)
Figure 46. Italy Blood PlasmaFractionation Consumption Value (2020-2031) & (USD Million)
Figure 47. Asia-Pacific Blood PlasmaFractionation Consumption Value Market Share byType (2020-2031)
Figure 48. Asia-Pacific Blood PlasmaFractionation Consumption Value Market Share by Application (2020-2031)
Figure 49. Asia-Pacific Blood PlasmaFractionation Consumption Value Market Share by Region (2020-2031)
Figure 50. China Blood PlasmaFractionation Consumption Value (2020-2031) & (USD Million)
Figure 51. Japan Blood PlasmaFractionation Consumption Value (2020-2031) & (USD Million)
Figure 52. South Korea Blood PlasmaFractionation Consumption Value (2020-2031) & (USD Million)
Figure 53. India Blood PlasmaFractionation Consumption Value (2020-2031) & (USD Million)
Figure 54. Southeast Asia Blood PlasmaFractionation Consumption Value (2020-2031) & (USD Million)
Figure 55. Australia Blood PlasmaFractionation Consumption Value (2020-2031) & (USD Million)
Figure 56. South America Blood PlasmaFractionation Consumption Value Market Share byType (2020-2031)
Figure 57. South America Blood PlasmaFractionation Consumption Value Market Share by Application (2020-2031)
Figure 58. South America Blood PlasmaFractionation Consumption Value Market Share by Country (2020-2031)
Figure 59. Brazil Blood PlasmaFractionation Consumption Value (2020-2031) & (USD Million)
Figure 60. Argentina Blood PlasmaFractionation Consumption Value (2020-2031) & (USD Million)
Figure 61. Middle East & Africa Blood PlasmaFractionation Consumption Value Market Share byType (2020-2031)
Figure 62. Middle East & Africa Blood PlasmaFractionation Consumption Value Market Share by Application (2020-2031)
Figure 63. Middle East & Africa Blood PlasmaFractionation Consumption Value Market Share by Country (2020-2031)
Figure 64.Turkey Blood PlasmaFractionation Consumption Value (2020-2031) & (USD Million)
Figure 65. Saudi Arabia Blood PlasmaFractionation Consumption Value (2020-2031) & (USD Million)
Figure 66. UAE Blood PlasmaFractionation Consumption Value (2020-2031) & (USD Million)
Figure 67. Blood PlasmaFractionation Market Drivers
Figure 68. Blood PlasmaFractionation Market Restraints
Figure 69. Blood PlasmaFractionation MarketTrends
Figure 70. PortersFiveForces Analysis
Figure 71. Blood PlasmaFractionation Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Blood Plasma Fractionation by Type
1.3.1 Overview: Global Blood Plasma Fractionation Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Blood Plasma Fractionation Consumption Value Market Share by Type in 2024
1.3.3 Immune Globulin
1.3.4 Coagulation Factor
1.3.5 Albumin
1.3.6 Other
1.4 Global Blood Plasma Fractionation Market by Application
1.4.1 Overview: Global Blood Plasma Fractionation Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospital
1.4.3 Retail Pharmacy
1.4.4 Other
1.5 Global Blood Plasma Fractionation Market Size & Forecast
1.6 Global Blood Plasma Fractionation Market Size and Forecast by Region
1.6.1 Global Blood Plasma Fractionation Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Blood Plasma Fractionation Market Size by Region, (2020-2031)
1.6.3 North America Blood Plasma Fractionation Market Size and Prospect (2020-2031)
1.6.4 Europe Blood Plasma Fractionation Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Blood Plasma Fractionation Market Size and Prospect (2020-2031)
1.6.6 South America Blood Plasma Fractionation Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Blood Plasma Fractionation Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Takeda
2.1.1 Takeda Details
2.1.2 Takeda Major Business
2.1.3 Takeda Blood Plasma Fractionation Product and Solutions
2.1.4 Takeda Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Takeda Recent Developments and Future Plans
2.2 CSL
2.2.1 CSL Details
2.2.2 CSL Major Business
2.2.3 CSL Blood Plasma Fractionation Product and Solutions
2.2.4 CSL Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 CSL Recent Developments and Future Plans
2.3 Grifols
2.3.1 Grifols Details
2.3.2 Grifols Major Business
2.3.3 Grifols Blood Plasma Fractionation Product and Solutions
2.3.4 Grifols Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Grifols Recent Developments and Future Plans
2.4 Octapharma
2.4.1 Octapharma Details
2.4.2 Octapharma Major Business
2.4.3 Octapharma Blood Plasma Fractionation Product and Solutions
2.4.4 Octapharma Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Octapharma Recent Developments and Future Plans
2.5 Kedrion
2.5.1 Kedrion Details
2.5.2 Kedrion Major Business
2.5.3 Kedrion Blood Plasma Fractionation Product and Solutions
2.5.4 Kedrion Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Kedrion Recent Developments and Future Plans
2.6 LFB Group
2.6.1 LFB Group Details
2.6.2 LFB Group Major Business
2.6.3 LFB Group Blood Plasma Fractionation Product and Solutions
2.6.4 LFB Group Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 LFB Group Recent Developments and Future Plans
2.7 Biotest
2.7.1 Biotest Details
2.7.2 Biotest Major Business
2.7.3 Biotest Blood Plasma Fractionation Product and Solutions
2.7.4 Biotest Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Biotest Recent Developments and Future Plans
2.8 BPL
2.8.1 BPL Details
2.8.2 BPL Major Business
2.8.3 BPL Blood Plasma Fractionation Product and Solutions
2.8.4 BPL Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 BPL Recent Developments and Future Plans
2.9 RAAS
2.9.1 RAAS Details
2.9.2 RAAS Major Business
2.9.3 RAAS Blood Plasma Fractionation Product and Solutions
2.9.4 RAAS Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 RAAS Recent Developments and Future Plans
2.10 CBPO
2.10.1 CBPO Details
2.10.2 CBPO Major Business
2.10.3 CBPO Blood Plasma Fractionation Product and Solutions
2.10.4 CBPO Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 CBPO Recent Developments and Future Plans
2.11 Hualan Bio
2.11.1 Hualan Bio Details
2.11.2 Hualan Bio Major Business
2.11.3 Hualan Bio Blood Plasma Fractionation Product and Solutions
2.11.4 Hualan Bio Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Hualan Bio Recent Developments and Future Plans
2.12 Tiantan Bio
2.12.1 Tiantan Bio Details
2.12.2 Tiantan Bio Major Business
2.12.3 Tiantan Bio Blood Plasma Fractionation Product and Solutions
2.12.4 Tiantan Bio Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Tiantan Bio Recent Developments and Future Plans
2.13 Shuanglin Bio
2.13.1 Shuanglin Bio Details
2.13.2 Shuanglin Bio Major Business
2.13.3 Shuanglin Bio Blood Plasma Fractionation Product and Solutions
2.13.4 Shuanglin Bio Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Shuanglin Bio Recent Developments and Future Plans
2.14 Boya Bio
2.14.1 Boya Bio Details
2.14.2 Boya Bio Major Business
2.14.3 Boya Bio Blood Plasma Fractionation Product and Solutions
2.14.4 Boya Bio Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Boya Bio Recent Developments and Future Plans
2.15 Yuanda Shuyang
2.15.1 Yuanda Shuyang Details
2.15.2 Yuanda Shuyang Major Business
2.15.3 Yuanda Shuyang Blood Plasma Fractionation Product and Solutions
2.15.4 Yuanda Shuyang Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Yuanda Shuyang Recent Developments and Future Plans
2.16 Weiguang Bio
2.16.1 Weiguang Bio Details
2.16.2 Weiguang Bio Major Business
2.16.3 Weiguang Bio Blood Plasma Fractionation Product and Solutions
2.16.4 Weiguang Bio Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Weiguang Bio Recent Developments and Future Plans
2.17 Nanyue Bio
2.17.1 Nanyue Bio Details
2.17.2 Nanyue Bio Major Business
2.17.3 Nanyue Bio Blood Plasma Fractionation Product and Solutions
2.17.4 Nanyue Bio Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 Nanyue Bio Recent Developments and Future Plans
2.18 KM Biologics
2.18.1 KM Biologics Details
2.18.2 KM Biologics Major Business
2.18.3 KM Biologics Blood Plasma Fractionation Product and Solutions
2.18.4 KM Biologics Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
2.18.5 KM Biologics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Blood Plasma Fractionation Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Blood Plasma Fractionation by Company Revenue
3.2.2 Top 3 Blood Plasma Fractionation Players Market Share in 2024
3.2.3 Top 6 Blood Plasma Fractionation Players Market Share in 2024
3.3 Blood Plasma Fractionation Market: Overall Company Footprint Analysis
3.3.1 Blood Plasma Fractionation Market: Region Footprint
3.3.2 Blood Plasma Fractionation Market: Company Product Type Footprint
3.3.3 Blood Plasma Fractionation Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Blood Plasma Fractionation Consumption Value and Market Share by Type (2020-2025)
4.2 Global Blood Plasma Fractionation Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Blood Plasma Fractionation Consumption Value Market Share by Application (2020-2025)
5.2 Global Blood Plasma Fractionation Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Blood Plasma Fractionation Consumption Value by Type (2020-2031)
6.2 North America Blood Plasma Fractionation Market Size by Application (2020-2031)
6.3 North America Blood Plasma Fractionation Market Size by Country
6.3.1 North America Blood Plasma Fractionation Consumption Value by Country (2020-2031)
6.3.2 United States Blood Plasma Fractionation Market Size and Forecast (2020-2031)
6.3.3 Canada Blood Plasma Fractionation Market Size and Forecast (2020-2031)
6.3.4 Mexico Blood Plasma Fractionation Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Blood Plasma Fractionation Consumption Value by Type (2020-2031)
7.2 Europe Blood Plasma Fractionation Consumption Value by Application (2020-2031)
7.3 Europe Blood Plasma Fractionation Market Size by Country
7.3.1 Europe Blood Plasma Fractionation Consumption Value by Country (2020-2031)
7.3.2 Germany Blood Plasma Fractionation Market Size and Forecast (2020-2031)
7.3.3 France Blood Plasma Fractionation Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Blood Plasma Fractionation Market Size and Forecast (2020-2031)
7.3.5 Russia Blood Plasma Fractionation Market Size and Forecast (2020-2031)
7.3.6 Italy Blood Plasma Fractionation Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Blood Plasma Fractionation Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Blood Plasma Fractionation Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Blood Plasma Fractionation Market Size by Region
8.3.1 Asia-Pacific Blood Plasma Fractionation Consumption Value by Region (2020-2031)
8.3.2 China Blood Plasma Fractionation Market Size and Forecast (2020-2031)
8.3.3 Japan Blood Plasma Fractionation Market Size and Forecast (2020-2031)
8.3.4 South Korea Blood Plasma Fractionation Market Size and Forecast (2020-2031)
8.3.5 India Blood Plasma Fractionation Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Blood Plasma Fractionation Market Size and Forecast (2020-2031)
8.3.7 Australia Blood Plasma Fractionation Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Blood Plasma Fractionation Consumption Value by Type (2020-2031)
9.2 South America Blood Plasma Fractionation Consumption Value by Application (2020-2031)
9.3 South America Blood Plasma Fractionation Market Size by Country
9.3.1 South America Blood Plasma Fractionation Consumption Value by Country (2020-2031)
9.3.2 Brazil Blood Plasma Fractionation Market Size and Forecast (2020-2031)
9.3.3 Argentina Blood Plasma Fractionation Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Blood Plasma Fractionation Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Blood Plasma Fractionation Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Blood Plasma Fractionation Market Size by Country
10.3.1 Middle East & Africa Blood Plasma Fractionation Consumption Value by Country (2020-2031)
10.3.2 Turkey Blood Plasma Fractionation Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Blood Plasma Fractionation Market Size and Forecast (2020-2031)
10.3.4 UAE Blood Plasma Fractionation Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Blood Plasma Fractionation Market Drivers
11.2 Blood Plasma Fractionation Market Restraints
11.3 Blood Plasma Fractionation Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Blood Plasma Fractionation Industry Chain
12.2 Blood Plasma Fractionation Upstream Analysis
12.3 Blood Plasma Fractionation Midstream Analysis
12.4 Blood Plasma Fractionation Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OFTABLES
Table 1. Global Blood PlasmaFractionation Consumption Value byType, (USD Million), 2020 & 2024 & 2031
Table 2. Global Blood PlasmaFractionation Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Blood PlasmaFractionation Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Blood PlasmaFractionation Consumption Value by Region (2026-2031) & (USD Million)
Table 5.Takeda Company Information, Head Office, and Major Competitors
Table 6.Takeda Major Business
Table 7.Takeda Blood PlasmaFractionation Product and Solutions
Table 8.Takeda Blood PlasmaFractionation Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9.Takeda Recent Developments andFuture Plans
Table 10. CSL Company Information, Head Office, and Major Competitors
Table 11. CSL Major Business
Table 12. CSL Blood PlasmaFractionation Product and Solutions
Table 13. CSL Blood PlasmaFractionation Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. CSL Recent Developments andFuture Plans
Table 15. Grifols Company Information, Head Office, and Major Competitors
Table 16. Grifols Major Business
Table 17. Grifols Blood PlasmaFractionation Product and Solutions
Table 18. Grifols Blood PlasmaFractionation Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Octapharma Company Information, Head Office, and Major Competitors
Table 20. Octapharma Major Business
Table 21. Octapharma Blood PlasmaFractionation Product and Solutions
Table 22. Octapharma Blood PlasmaFractionation Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Octapharma Recent Developments andFuture Plans
Table 24. Kedrion Company Information, Head Office, and Major Competitors
Table 25. Kedrion Major Business
Table 26. Kedrion Blood PlasmaFractionation Product and Solutions
Table 27. Kedrion Blood PlasmaFractionation Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Kedrion Recent Developments andFuture Plans
Table 29. LFB Group Company Information, Head Office, and Major Competitors
Table 30. LFB Group Major Business
Table 31. LFB Group Blood PlasmaFractionation Product and Solutions
Table 32. LFB Group Blood PlasmaFractionation Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. LFB Group Recent Developments andFuture Plans
Table 34. Biotest Company Information, Head Office, and Major Competitors
Table 35. Biotest Major Business
Table 36. Biotest Blood PlasmaFractionation Product and Solutions
Table 37. Biotest Blood PlasmaFractionation Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Biotest Recent Developments andFuture Plans
Table 39. BPL Company Information, Head Office, and Major Competitors
Table 40. BPL Major Business
Table 41. BPL Blood PlasmaFractionation Product and Solutions
Table 42. BPL Blood PlasmaFractionation Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. BPL Recent Developments andFuture Plans
Table 44. RAAS Company Information, Head Office, and Major Competitors
Table 45. RAAS Major Business
Table 46. RAAS Blood PlasmaFractionation Product and Solutions
Table 47. RAAS Blood PlasmaFractionation Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. RAAS Recent Developments andFuture Plans
Table 49. CBPO Company Information, Head Office, and Major Competitors
Table 50. CBPO Major Business
Table 51. CBPO Blood PlasmaFractionation Product and Solutions
Table 52. CBPO Blood PlasmaFractionation Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. CBPO Recent Developments andFuture Plans
Table 54. Hualan Bio Company Information, Head Office, and Major Competitors
Table 55. Hualan Bio Major Business
Table 56. Hualan Bio Blood PlasmaFractionation Product and Solutions
Table 57. Hualan Bio Blood PlasmaFractionation Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. Hualan Bio Recent Developments andFuture Plans
Table 59.Tiantan Bio Company Information, Head Office, and Major Competitors
Table 60.Tiantan Bio Major Business
Table 61.Tiantan Bio Blood PlasmaFractionation Product and Solutions
Table 62.Tiantan Bio Blood PlasmaFractionation Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63.Tiantan Bio Recent Developments andFuture Plans
Table 64. Shuanglin Bio Company Information, Head Office, and Major Competitors
Table 65. Shuanglin Bio Major Business
Table 66. Shuanglin Bio Blood PlasmaFractionation Product and Solutions
Table 67. Shuanglin Bio Blood PlasmaFractionation Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 68. Shuanglin Bio Recent Developments andFuture Plans
Table 69. Boya Bio Company Information, Head Office, and Major Competitors
Table 70. Boya Bio Major Business
Table 71. Boya Bio Blood PlasmaFractionation Product and Solutions
Table 72. Boya Bio Blood PlasmaFractionation Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 73. Boya Bio Recent Developments andFuture Plans
Table 74. Yuanda Shuyang Company Information, Head Office, and Major Competitors
Table 75. Yuanda Shuyang Major Business
Table 76. Yuanda Shuyang Blood PlasmaFractionation Product and Solutions
Table 77. Yuanda Shuyang Blood PlasmaFractionation Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 78. Yuanda Shuyang Recent Developments andFuture Plans
Table 79. Weiguang Bio Company Information, Head Office, and Major Competitors
Table 80. Weiguang Bio Major Business
Table 81. Weiguang Bio Blood PlasmaFractionation Product and Solutions
Table 82. Weiguang Bio Blood PlasmaFractionation Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 83. Weiguang Bio Recent Developments andFuture Plans
Table 84. Nanyue Bio Company Information, Head Office, and Major Competitors
Table 85. Nanyue Bio Major Business
Table 86. Nanyue Bio Blood PlasmaFractionation Product and Solutions
Table 87. Nanyue Bio Blood PlasmaFractionation Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 88. Nanyue Bio Recent Developments andFuture Plans
Table 89. KM Biologics Company Information, Head Office, and Major Competitors
Table 90. KM Biologics Major Business
Table 91. KM Biologics Blood PlasmaFractionation Product and Solutions
Table 92. KM Biologics Blood PlasmaFractionation Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 93. KM Biologics Recent Developments andFuture Plans
Table 94. Global Blood PlasmaFractionation Revenue (USD Million) by Players (2020-2025)
Table 95. Global Blood PlasmaFractionation Revenue Share by Players (2020-2025)
Table 96. Breakdown of Blood PlasmaFractionation by CompanyType (Tier 1,Tier 2, andTier 3)
Table 97. Market Position of Players in Blood PlasmaFractionation, (Tier 1,Tier 2, andTier 3), Based on Revenue in 2024
Table 98. Head Office of Key Blood PlasmaFractionation Players
Table 99. Blood PlasmaFractionation Market: Company ProductTypeFootprint
Table 100. Blood PlasmaFractionation Market: Company Product ApplicationFootprint
Table 101. Blood PlasmaFractionation New Market Entrants and Barriers to Market Entry
Table 102. Blood PlasmaFractionation Mergers, Acquisition, Agreements, and Collaborations
Table 103. Global Blood PlasmaFractionation Consumption Value (USD Million) byType (2020-2025)
Table 104. Global Blood PlasmaFractionation Consumption Value Share byType (2020-2025)
Table 105. Global Blood PlasmaFractionation Consumption ValueForecast byType (2026-2031)
Table 106. Global Blood PlasmaFractionation Consumption Value by Application (2020-2025)
Table 107. Global Blood PlasmaFractionation Consumption ValueForecast by Application (2026-2031)
Table 108. North America Blood PlasmaFractionation Consumption Value byType (2020-2025) & (USD Million)
Table 109. North America Blood PlasmaFractionation Consumption Value byType (2026-2031) & (USD Million)
Table 110. North America Blood PlasmaFractionation Consumption Value by Application (2020-2025) & (USD Million)
Table 111. North America Blood PlasmaFractionation Consumption Value by Application (2026-2031) & (USD Million)
Table 112. North America Blood PlasmaFractionation Consumption Value by Country (2020-2025) & (USD Million)
Table 113. North America Blood PlasmaFractionation Consumption Value by Country (2026-2031) & (USD Million)
Table 114. Europe Blood PlasmaFractionation Consumption Value byType (2020-2025) & (USD Million)
Table 115. Europe Blood PlasmaFractionation Consumption Value byType (2026-2031) & (USD Million)
Table 116. Europe Blood PlasmaFractionation Consumption Value by Application (2020-2025) & (USD Million)
Table 117. Europe Blood PlasmaFractionation Consumption Value by Application (2026-2031) & (USD Million)
Table 118. Europe Blood PlasmaFractionation Consumption Value by Country (2020-2025) & (USD Million)
Table 119. Europe Blood PlasmaFractionation Consumption Value by Country (2026-2031) & (USD Million)
Table 120. Asia-Pacific Blood PlasmaFractionation Consumption Value byType (2020-2025) & (USD Million)
Table 121. Asia-Pacific Blood PlasmaFractionation Consumption Value byType (2026-2031) & (USD Million)
Table 122. Asia-Pacific Blood PlasmaFractionation Consumption Value by Application (2020-2025) & (USD Million)
Table 123. Asia-Pacific Blood PlasmaFractionation Consumption Value by Application (2026-2031) & (USD Million)
Table 124. Asia-Pacific Blood PlasmaFractionation Consumption Value by Region (2020-2025) & (USD Million)
Table 125. Asia-Pacific Blood PlasmaFractionation Consumption Value by Region (2026-2031) & (USD Million)
Table 126. South America Blood PlasmaFractionation Consumption Value byType (2020-2025) & (USD Million)
Table 127. South America Blood PlasmaFractionation Consumption Value byType (2026-2031) & (USD Million)
Table 128. South America Blood PlasmaFractionation Consumption Value by Application (2020-2025) & (USD Million)
Table 129. South America Blood PlasmaFractionation Consumption Value by Application (2026-2031) & (USD Million)
Table 130. South America Blood PlasmaFractionation Consumption Value by Country (2020-2025) & (USD Million)
Table 131. South America Blood PlasmaFractionation Consumption Value by Country (2026-2031) & (USD Million)
Table 132. Middle East & Africa Blood PlasmaFractionation Consumption Value byType (2020-2025) & (USD Million)
Table 133. Middle East & Africa Blood PlasmaFractionation Consumption Value byType (2026-2031) & (USD Million)
Table 134. Middle East & Africa Blood PlasmaFractionation Consumption Value by Application (2020-2025) & (USD Million)
Table 135. Middle East & Africa Blood PlasmaFractionation Consumption Value by Application (2026-2031) & (USD Million)
Table 136. Middle East & Africa Blood PlasmaFractionation Consumption Value by Country (2020-2025) & (USD Million)
Table 137. Middle East & Africa Blood PlasmaFractionation Consumption Value by Country (2026-2031) & (USD Million)
Table 138. Global Key Players of Blood PlasmaFractionation Upstream (Raw Materials)
Table 139. Global Blood PlasmaFractionationTypical Customers
LIST OFFIGURES
Figure 1. Blood PlasmaFractionation Picture
Figure 2. Global Blood PlasmaFractionation Consumption Value byType, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Blood PlasmaFractionation Consumption Value Market Share byType in 2024
Figure 4. Immune Globulin
Figure 5. CoagulationFactor
Figure 6. Albumin
Figure 7. Other
Figure 8. Global Blood PlasmaFractionation Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 9. Blood PlasmaFractionation Consumption Value Market Share by Application in 2024
Figure 10. Hospital Picture
Figure 11. Retail Pharmacy Picture
Figure 12. Other Picture
Figure 13. Global Blood PlasmaFractionation Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 14. Global Blood PlasmaFractionation Consumption Value andForecast (2020-2031) & (USD Million)
Figure 15. Global Market Blood PlasmaFractionation Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 16. Global Blood PlasmaFractionation Consumption Value Market Share by Region (2020-2031)
Figure 17. Global Blood PlasmaFractionation Consumption Value Market Share by Region in 2024
Figure 18. North America Blood PlasmaFractionation Consumption Value (2020-2031) & (USD Million)
Figure 19. Europe Blood PlasmaFractionation Consumption Value (2020-2031) & (USD Million)
Figure 20. Asia-Pacific Blood PlasmaFractionation Consumption Value (2020-2031) & (USD Million)
Figure 21. South America Blood PlasmaFractionation Consumption Value (2020-2031) & (USD Million)
Figure 22. Middle East & Africa Blood PlasmaFractionation Consumption Value (2020-2031) & (USD Million)
Figure 23. CompanyThree Recent Developments andFuture Plans
Figure 24. Global Blood PlasmaFractionation Revenue Share by Players in 2024
Figure 25. Blood PlasmaFractionation Market Share by CompanyType (Tier 1,Tier 2, andTier 3) in 2024
Figure 26. Market Share of Blood PlasmaFractionation by Player Revenue in 2024
Figure 27.Top 3 Blood PlasmaFractionation Players Market Share in 2024
Figure 28.Top 6 Blood PlasmaFractionation Players Market Share in 2024
Figure 29. Global Blood PlasmaFractionation Consumption Value Share byType (2020-2025)
Figure 30. Global Blood PlasmaFractionation Market ShareForecast byType (2026-2031)
Figure 31. Global Blood PlasmaFractionation Consumption Value Share by Application (2020-2025)
Figure 32. Global Blood PlasmaFractionation Market ShareForecast by Application (2026-2031)
Figure 33. North America Blood PlasmaFractionation Consumption Value Market Share byType (2020-2031)
Figure 34. North America Blood PlasmaFractionation Consumption Value Market Share by Application (2020-2031)
Figure 35. North America Blood PlasmaFractionation Consumption Value Market Share by Country (2020-2031)
Figure 36. United States Blood PlasmaFractionation Consumption Value (2020-2031) & (USD Million)
Figure 37. Canada Blood PlasmaFractionation Consumption Value (2020-2031) & (USD Million)
Figure 38. Mexico Blood PlasmaFractionation Consumption Value (2020-2031) & (USD Million)
Figure 39. Europe Blood PlasmaFractionation Consumption Value Market Share byType (2020-2031)
Figure 40. Europe Blood PlasmaFractionation Consumption Value Market Share by Application (2020-2031)
Figure 41. Europe Blood PlasmaFractionation Consumption Value Market Share by Country (2020-2031)
Figure 42. Germany Blood PlasmaFractionation Consumption Value (2020-2031) & (USD Million)
Figure 43.France Blood PlasmaFractionation Consumption Value (2020-2031) & (USD Million)
Figure 44. United Kingdom Blood PlasmaFractionation Consumption Value (2020-2031) & (USD Million)
Figure 45. Russia Blood PlasmaFractionation Consumption Value (2020-2031) & (USD Million)
Figure 46. Italy Blood PlasmaFractionation Consumption Value (2020-2031) & (USD Million)
Figure 47. Asia-Pacific Blood PlasmaFractionation Consumption Value Market Share byType (2020-2031)
Figure 48. Asia-Pacific Blood PlasmaFractionation Consumption Value Market Share by Application (2020-2031)
Figure 49. Asia-Pacific Blood PlasmaFractionation Consumption Value Market Share by Region (2020-2031)
Figure 50. China Blood PlasmaFractionation Consumption Value (2020-2031) & (USD Million)
Figure 51. Japan Blood PlasmaFractionation Consumption Value (2020-2031) & (USD Million)
Figure 52. South Korea Blood PlasmaFractionation Consumption Value (2020-2031) & (USD Million)
Figure 53. India Blood PlasmaFractionation Consumption Value (2020-2031) & (USD Million)
Figure 54. Southeast Asia Blood PlasmaFractionation Consumption Value (2020-2031) & (USD Million)
Figure 55. Australia Blood PlasmaFractionation Consumption Value (2020-2031) & (USD Million)
Figure 56. South America Blood PlasmaFractionation Consumption Value Market Share byType (2020-2031)
Figure 57. South America Blood PlasmaFractionation Consumption Value Market Share by Application (2020-2031)
Figure 58. South America Blood PlasmaFractionation Consumption Value Market Share by Country (2020-2031)
Figure 59. Brazil Blood PlasmaFractionation Consumption Value (2020-2031) & (USD Million)
Figure 60. Argentina Blood PlasmaFractionation Consumption Value (2020-2031) & (USD Million)
Figure 61. Middle East & Africa Blood PlasmaFractionation Consumption Value Market Share byType (2020-2031)
Figure 62. Middle East & Africa Blood PlasmaFractionation Consumption Value Market Share by Application (2020-2031)
Figure 63. Middle East & Africa Blood PlasmaFractionation Consumption Value Market Share by Country (2020-2031)
Figure 64.Turkey Blood PlasmaFractionation Consumption Value (2020-2031) & (USD Million)
Figure 65. Saudi Arabia Blood PlasmaFractionation Consumption Value (2020-2031) & (USD Million)
Figure 66. UAE Blood PlasmaFractionation Consumption Value (2020-2031) & (USD Million)
Figure 67. Blood PlasmaFractionation Market Drivers
Figure 68. Blood PlasmaFractionation Market Restraints
Figure 69. Blood PlasmaFractionation MarketTrends
Figure 70. PortersFiveForces Analysis
Figure 71. Blood PlasmaFractionation Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
